ClinConnect ClinConnect Logo
Search / Trial NCT06840808

Treating Word Finding Difficulties in Traumatic Brain Injury With HD-tDCS

Launched by THE UNIVERSITY OF TEXAS AT DALLAS · Feb 17, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Electroencephalography Transcranial Direct Current Stimulation Cognition

ClinConnect Summary

This clinical trial is exploring a new way to help people who have had a traumatic brain injury (TBI) and struggle with finding the right words when speaking. The study is testing a method called transcranial Direct Current Stimulation (tDCS), which involves using a low level of electric stimulation on a specific part of the brain that is believed to help with memory. Researchers hope that this treatment will improve the ability to retrieve words in civilian participants who have experienced TBIs more than a year ago and have ongoing word-finding difficulties.

To participate in this study, individuals must be between 18 and 85 years old, have a history of mild to moderate traumatic brain injury confirmed by certain tests, and should not be military personnel or veterans. They also need to be fluent in English. Participants will undergo various assessments to measure their verbal abilities and overall cognitive skills before, during, and after the treatment. It’s important to know that some individuals, like those with specific medical conditions or devices, may not qualify for the study. If you or someone you know fits the criteria and is interested, this trial could provide valuable insights into improving communication after a brain injury.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Between the ages of 18-85
  • Traumatic brain injury more than a year prior to study participation
  • Word finding difficulty since the brain injury
  • Fluent in speaking and reading English.
  • Exclusion Criteria:
  • Implanted/electronic device, such as a pacemaker, metallic cranial or intracranial implant (e.g., ventriculoperitoneal shunt), or a neurostimulator (e.g., vagus nerve stimulator, spinal stimulator, deep brain stimulator, etc.).
  • Skull defects
  • History of a psychological or neurological disorder, including, dementia of any type, epilepsy or other seizure disorders, post-traumatic stress disorder, brain tumor, present drug abuse, stroke, blood vessel abnormalities in the brain, Parkinson's disease, Huntington's disease, or multiple sclerosis.
  • Inability to give informed consent
  • Military personnel or Veteran
  • Currently pregnant
  • Not fluent English speaker

About The University Of Texas At Dallas

The University of Texas at Dallas (UT Dallas) is a leading research institution dedicated to advancing knowledge and innovation across various disciplines, including health sciences and clinical research. As a clinical trial sponsor, UT Dallas leverages its robust academic infrastructure and interdisciplinary expertise to conduct rigorous studies aimed at improving patient outcomes and enhancing medical practices. The university fosters collaboration among researchers, clinicians, and industry partners, ensuring that its clinical trials adhere to the highest ethical standards and scientific integrity. Through its commitment to research excellence, UT Dallas aims to contribute significantly to the advancement of healthcare solutions and the understanding of complex medical conditions.

Locations

Richardson, Texas, United States

Patients applied

0 patients applied

Trial Officials

John Hart, MD

Principal Investigator

The University of Texas at Dallas

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported